Please login to the form below

Not currently logged in
Email:
Password:

New head of Lilly oncology

Eli Lilly has appointed Sue Mahony to the role of senior vice president and president of Lilly Oncology

Sue Mahony, currently senior vice president of human resources and diversity, is to become senior vice president and president of Lilly Oncology, replacing John H Johnson, who left the company last month.

Mahony will continue to report to CEO John Lechleiter and will remain on the company's executive committee. Her new position is effective immediately.

Since his departure from Lilly, Johnson has taken over the reins at Savient Pharmaceutical, which is in the process of bringing its gout drug Krystexxa (pegloticase) to market in the US. He was previously CEO of ImClone Systems, and joined Lilly when it acquired the cancer-focused biotech company in 2008.

Steve Fry, currently vice president of human resources for bio-medicines and emerging markets, will take Mahony's old post and will join Lilly's executive leadership team. Fry was managing director of Lilly's Australian affiliate from 2004 to 2007, before becoming executive director of HR for the intercontinental region and Japan. 

Mahony, who has been with Lilly for more than 10 years, was named to the top HR position in 2009. The year before, she had been promoted to serve as general manager of Lilly, following a number of positions in the company's global marketing and new product development operations.

Before joining Lilly, she spent a decade in sales and marketing roles in the UK and Europe in oncology/hematology and cardiovascular medicine for Amgen, Bristol-Myers Squibb (BMS), and Schering-Plough. She holds a PhD in pharmacy from Aston University in the UK, and an MBA from the London Business School. 

Lilly Oncology's portfolio of marketed drugs includes the non-small cell lung cancer treatment Alimta and the ovarian cancer therapy Gemzar. The company has also declared a commitment to developing personalised cancer medications.

11th February 2011

Share

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Healthcare Media Europe – HME Ltd

HME are an innovative and technology enabled agency offering our clients over 35+ years of knowledge and expertise in delivering...

Latest intelligence

Flu
Influenza – the risk to vulnerable populations
Why we can't get complacent about flu vaccination...
dementia
Alzheimer’s Research UK highlights socio-economic inequalities in dementia risk
The charity aims to improve the number of women participating in dementia research and grow awareness of dementia risk factors...
Data security
Concerns about data security are building a strong case for clinical mobility in EMEA
Electronic medical records have transformed the storage of sensitive information but how can the healthcare sector continue to protect patient and staff data?...